Literature DB >> 25117712

Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models.

Liem H Nguyen1, Daisy A Robinton2, Marc T Seligson2, Linwei Wu3, Lin Li1, Dinesh Rakheja4, Sarah A Comerford5, Saleh Ramezani6, Xiankai Sun6, Monisha S Parikh1, Erin H Yang1, John T Powers2, Gen Shinoda2, Samar P Shah2, Robert E Hammer7, George Q Daley8, Hao Zhu9.   

Abstract

Lin28a/b are RNA-binding proteins that influence stem cell maintenance, metabolism, and oncogenesis. Poorly differentiated, aggressive cancers often overexpress Lin28, but its role in tumor initiation or maintenance has not been definitively addressed. We report that LIN28B overexpression is sufficient to initiate hepatoblastoma and hepatocellular carcinoma in murine models. We also detected Lin28b overexpression in MYC-driven hepatoblastomas, and liver-specific deletion of Lin28a/b reduced tumor burden, extended latency, and prolonged survival. Both intravenous siRNA against Lin28b and conditional Lin28b deletion reduced tumor burden and prolonged survival. Igf2bp proteins are upregulated, and Igf2bp3 is required in the context of LIN28B overexpression to promote growth. Therefore, multiple murine models demonstrate that Lin28b is both sufficient to initiate liver cancer and necessary for its maintenance.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25117712      PMCID: PMC4145706          DOI: 10.1016/j.ccr.2014.06.018

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  54 in total

1.  Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma.

Authors:  Yingqiu Guo; Yongxin Chen; Hirotaka Ito; Akira Watanabe; Xijin Ge; Tatsuhiko Kodama; Hiroyuki Aburatani
Journal:  Gene       Date:  2006-07-28       Impact factor: 3.688

2.  Lin28 modulates cell growth and associates with a subset of cell cycle regulator mRNAs in mouse embryonic stem cells.

Authors:  Bingsen Xu; Kexiong Zhang; Yingqun Huang
Journal:  RNA       Date:  2009-01-15       Impact factor: 4.942

3.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

4.  Lin-28 homologue A (LIN28A) promotes cell cycle progression via regulation of cyclin-dependent kinase 2 (CDK2), cyclin D1 (CCND1), and cell division cycle 25 homolog A (CDC25A) expression in cancer.

Authors:  Ning Li; Xiaomin Zhong; Xiaojuan Lin; Jinyi Guo; Lian Zou; Janos L Tanyi; Zhongjun Shao; Shun Liang; Li-Ping Wang; Wei-Ting Hwang; Dionyssios Katsaros; Kathleen Montone; Xia Zhao; Lin Zhang
Journal:  J Biol Chem       Date:  2012-03-30       Impact factor: 5.157

5.  Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma.

Authors:  Elisa Wurmbach; Ying-bei Chen; Greg Khitrov; Weijia Zhang; Sasan Roayaie; Myron Schwartz; Isabel Fiel; Swan Thung; Vincenzo Mazzaferro; Jordi Bruix; Erwin Bottinger; Scott Friedman; Samuel Waxman; Josep M Llovet
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

6.  LIN28 binds messenger RNAs at GGAGA motifs and regulates splicing factor abundance.

Authors:  Melissa L Wilbert; Stephanie C Huelga; Katannya Kapeli; Thomas J Stark; Tiffany Y Liang; Stella X Chen; Bernice Y Yan; Jason L Nathanson; Kasey R Hutt; Michael T Lovci; Hilal Kazan; Anthony Q Vu; Katlin B Massirer; Quaid Morris; Shawn Hoon; Gene W Yeo
Journal:  Mol Cell       Date:  2012-09-06       Impact factor: 17.970

7.  The Lin28/let-7 axis regulates glucose metabolism.

Authors:  Hao Zhu; Ng Shyh-Chang; Ayellet V Segrè; Gen Shinoda; Samar P Shah; William S Einhorn; Ayumu Takeuchi; Jesse M Engreitz; John P Hagan; Michael G Kharas; Achia Urbach; James E Thornton; Robinson Triboulet; Richard I Gregory; David Altshuler; George Q Daley
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

8.  Detection of IGF2BP3, HOXB7, and NEK2 mRNA expression in brush cytology specimens as a new diagnostic tool in patients with biliary strictures.

Authors:  Hans Dieter Nischalke; Volker Schmitz; Carolin Luda; Katharina Aldenhoff; Cordula Berger; Georg Feldmann; Tilman Sauerbruch; Ulrich Spengler; Jacob Nattermann
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

9.  A computational study of off-target effects of RNA interference.

Authors:  Shibin Qiu; Coen M Adema; Terran Lane
Journal:  Nucleic Acids Res       Date:  2005-03-30       Impact factor: 16.971

10.  Selective blockade of microRNA processing by Lin28.

Authors:  Srinivas R Viswanathan; George Q Daley; Richard I Gregory
Journal:  Science       Date:  2008-02-21       Impact factor: 47.728

View more
  95 in total

1.  Preface to the column "Metabolism of Childhood Cancer".

Authors:  Dinesh Rakheja
Journal:  Transl Pediatr       Date:  2015-01

Review 2.  Lin28 and let-7 in cell metabolism and cancer.

Authors:  Liem H Nguyen; Hao Zhu
Journal:  Transl Pediatr       Date:  2015-01

3.  The RNA-binding protein SART3 promotes miR-34a biogenesis and G1 cell cycle arrest in lung cancer cells.

Authors:  Emily J Sherman; Dylan C Mitchell; Amanda L Garner
Journal:  J Biol Chem       Date:  2019-10-16       Impact factor: 5.157

4.  Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.

Authors:  Chong Chen; Lipeng Bai; Fengqi Cao; Shengnan Wang; Huiwen He; Mingcheng Song; Huilin Chen; Yan Liu; Jian Guo; Qin Si; Yundi Pan; Ruizhe Zhu; Tsung-Hsien Chuang; Rong Xiang; Yunping Luo
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

5.  A cancer-testis non-coding RNA LIN28B-AS1 activates driver gene LIN28B by interacting with IGF2BP1 in lung adenocarcinoma.

Authors:  Cheng Wang; Yayun Gu; Erbao Zhang; Kai Zhang; Na Qin; Juncheng Dai; Meng Zhu; Jia Liu; Kaipeng Xie; Yue Jiang; Xuejiang Guo; Mingxi Liu; Guangfu Jin; Hongxia Ma; Tao Jiang; Rong Yin; Yankai Xia; Li Liu; Shouyu Wang; Bin Shen; Ran Huo; Lin Xu; Jiahao Sha; Bin Qu; Hongbing Shen; Zhibin Hu
Journal:  Oncogene       Date:  2018-10-23       Impact factor: 9.867

6.  Chain length of saturated fatty acids regulates mitochondrial trafficking and function in sensory neurons.

Authors:  Amy E Rumora; Giovanni LoGrasso; Julia A Haidar; Justin J Dolkowski; Stephen I Lentz; Eva L Feldman
Journal:  J Lipid Res       Date:  2018-11-15       Impact factor: 5.922

7.  Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant β-catenin.

Authors:  Sarah A Comerford; Elizabeth A Hinnant; Yidong Chen; Hima Bansal; Shawn Klapproth; Dinesh Rakheja; Milton J Finegold; Dolores Lopez-Terrada; Kathryn A O'Donnell; Gail E Tomlinson; Robert E Hammer
Journal:  JCI Insight       Date:  2016-10-06

Review 8.  Hepatoblastoma: current knowledge and promises from preclinical studies.

Authors:  Diego F Calvisi; Antonio Solinas
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

9.  Lin28 enhances de novo fatty acid synthesis to promote cancer progression via SREBP-1.

Authors:  Yang Zhang; Chenchen Li; Chuanzhen Hu; Qian Wu; Yongping Cai; Songge Xing; Hui Lu; Lin Wang; Linchong Sun; Tingting Li; Xiaoping He; Xiuying Zhong; Junfeng Wang; Ping Gao; Zachary J Smith; Weidong Jia; Huafeng Zhang
Journal:  EMBO Rep       Date:  2019-08-05       Impact factor: 8.807

10.  Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons.

Authors:  Amy E Rumora; Stephen I Lentz; Lucy M Hinder; Samuel W Jackson; Andrew Valesano; Gideon E Levinson; Eva L Feldman
Journal:  FASEB J       Date:  2017-09-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.